Q3  2024 |
≡ |
Torray Funds |
Add 0.07% |
109 |
0.00 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 3.06% |
1,137 |
0.02 |
≡ |
Francois Rochon - Giverny Capital |
Add 3.37% |
16,345 |
0.11 |
≡ |
Robert Olstein - Olstein Capital Management |
Add 30.77% |
4,000 |
0.12 |
≡ |
Dodge & Cox |
Reduce 5.60% |
1,300,800 |
0.21 |
≡ |
John Armitage - Egerton Capital |
Reduce 5.78% |
158,255 |
0.29 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 30.68% |
58,820 |
0.52 |
≡ |
ValueAct Capital |
Sell 100.00% |
1,103,759 |
4.63 |
Q2  2024 |
≡ |
Torray Funds |
Reduce 0.07% |
110 |
0.00 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 1.83% |
690 |
0.01 |
≡ |
Francois Rochon - Giverny Capital |
Add 0.98% |
4,687 |
0.03 |
≡ |
Bill Nygren - Oakmark Select Fund |
Add 8.42% |
110,588 |
0.29 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 17.89% |
41,755 |
0.33 |
≡ |
Robert Olstein - Olstein Capital Management |
Buy |
13,000 |
0.34 |
≡ |
John Armitage - Egerton Capital |
Reduce 19.32% |
655,536 |
0.99 |
≡ |
ValueAct Capital |
Reduce 69.81% |
2,551,882 |
10.70 |
Q1  2024 |
≡ |
Torray Funds |
Reduce 0.61% |
927 |
0.02 |
≡ |
John Armitage - Egerton Capital |
Reduce 1.62% |
56,007 |
0.09 |
≡ |
Francois Rochon - Giverny Capital |
Add 5.58% |
25,372 |
0.16 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 9.05% |
23,234 |
0.18 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 49.97% |
37,751 |
0.72 |
≡ |
ValueAct Capital |
Reduce 12.73% |
533,200 |
1.88 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 45.67% |
149,986 |
2.11 |
Q4  2023 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
5,087 |
0.01 |
≡ |
Torray Funds |
Add 0.35% |
528 |
0.01 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 7.24% |
5,894 |
0.10 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 5.15% |
13,947 |
0.10 |
≡ |
John Armitage - Egerton Capital |
Reduce 2.57% |
91,085 |
0.13 |
≡ |
Bill Nygren - Oakmark Select Fund |
Reduce 5.92% |
82,588 |
0.19 |
≡ |
Leon Cooperman |
Add 7.87% |
35,000 |
0.22 |
≡ |
Francois Rochon - Giverny Capital |
Add 42.55% |
135,780 |
0.85 |
≡ |
ValueAct Capital |
Reduce 44.51% |
3,360,000 |
8.94 |
Q3  2023 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 38.38% |
3,169 |
0.01 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 0.92% |
760 |
0.01 |
≡ |
Dodge & Cox |
Reduce 0.17% |
40,600 |
0.01 |
≡ |
Torray Funds |
Reduce 1.40% |
2,158 |
0.04 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 6.55% |
18,983 |
0.13 |
≡ |
John Armitage - Egerton Capital |
Add 4.69% |
158,524 |
0.21 |
≡ |
Francois Rochon - Giverny Capital |
Add 17.74% |
48,088 |
0.30 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 17.53% |
69,805 |
0.64 |
≡ |
ValueAct Capital |
Reduce 35.19% |
4,098,935 |
10.40 |
Q2  2023 |
≡ |
Bill Nygren - Oakmark Select Fund |
Reduce 0.02% |
312 |
0.00 |
≡ |
Dodge & Cox |
Add 0.36% |
83,500 |
0.01 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
8,256 |
0.02 |
≡ |
Torray Funds |
Reduce 0.56% |
860 |
0.02 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 1.93% |
1,616 |
0.03 |
≡ |
Francois Rochon - Giverny Capital |
Add 3.96% |
10,335 |
0.07 |
≡ |
Mairs & Power Growth Fund |
Reduce 4.07% |
42,000 |
0.11 |
≡ |
John Armitage - Egerton Capital |
Reduce 3.38% |
118,355 |
0.15 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 14.21% |
65,983 |
0.63 |
≡ |
Seth Klarman - Baupost Group |
Sell 100.00% |
533,382 |
1.08 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 442.09% |
236,184 |
1.66 |
≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
287,648 |
2.03 |
Q1  2023 |
≡ |
Torray Funds |
Reduce 0.14% |
215 |
0.00 |
≡ |
Bill Nygren - Oakmark Select Fund |
Add 0.02% |
312 |
0.00 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 5.24% |
4,632 |
0.08 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 18.93% |
12,475 |
0.63 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 24.80% |
94,842 |
0.67 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 28.92% |
188,895 |
1.69 |
≡ |
Francois Rochon - Giverny Capital |
Buy |
260,671 |
1.77 |
≡ |
Seth Klarman - Baupost Group |
Reduce 73.36% |
1,469,009 |
2.97 |
≡ |
John Armitage - Egerton Capital |
Buy |
3,499,199 |
4.27 |
≡ |
ValueAct Capital |
Reduce 20.48% |
3,000,000 |
5.52 |
Q4  2022 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 2.64% |
2,402 |
0.04 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 11.78% |
8,800 |
0.44 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 20.94% |
101,302 |
0.66 |
≡ |
Bill Nygren - Oakmark Select Fund |
Reduce 30.06% |
600,000 |
1.49 |
≡ |
Torray Funds |
Add 177.45% |
99,187 |
1.80 |
≡ |
Seth Klarman - Baupost Group |
Reduce 43.31% |
1,530,000 |
2.63 |
Q3  2022 |
≡ |
Dodge & Cox |
Add 0.20% |
45,500 |
0.01 |
≡ |
David Katz - Matrix Asset Advisors |
Add 3.13% |
2,754 |
0.04 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 1.97% |
1,500 |
0.07 |
≡ |
Mairs & Power Growth Fund |
Reduce 4.54% |
49,000 |
0.11 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 17.84% |
105,021 |
0.60 |
≡ |
Bill Nygren - Oakmark Select Fund |
Reduce 13.22% |
304,000 |
0.71 |
≡ |
Torray Funds |
Reduce 71.98% |
143,557 |
2.67 |
≡ |
Leon Cooperman |
Reduce 48.26% |
415,000 |
2.72 |
Q2  2022 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 6.43% |
40,468 |
0.20 |
≡ |
Torray Funds |
Reduce 5.86% |
12,407 |
0.21 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 10.12% |
7,000 |
0.30 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 28.32% |
34,815 |
0.47 |
≡ |
Seth Klarman - Baupost Group |
Reduce 11.43% |
456,000 |
0.62 |
≡ |
Leon Cooperman |
Reduce 16.55% |
170,600 |
1.04 |
≡ |
ValueAct Capital |
Add 12.37% |
1,612,575 |
2.29 |
Q1  2022 |
≡ |
David Katz - Matrix Asset Advisors |
Add 0.94% |
1,149 |
0.02 |
≡ |
Dodge & Cox |
Add 2.91% |
655,100 |
0.07 |
≡ |
Torray Funds |
Add 3.84% |
7,828 |
0.13 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 5.49% |
3,600 |
0.14 |
≡ |
Mairs & Power Growth Fund |
Reduce 6.90% |
80,000 |
0.15 |
≡ |
Bill Miller - Miller Value Partners |
Add 24.02% |
121,898 |
0.47 |
≡ |
Bill Nygren - Oakmark Select Fund |
Reduce 9.80% |
250,000 |
0.52 |
≡ |
Seth Klarman - Baupost Group |
Add 30.77% |
938,391 |
1.05 |
≡ |
Mason Hawkins - Longleaf Partners |
Add 133.37% |
373,248 |
2.26 |
≡ |
Leon Cooperman |
Buy |
1,030,600 |
5.50 |
Q4  2021 |
≡ |
Torray Funds |
Reduce 0.36% |
734 |
0.01 |
≡ |
David Katz - Matrix Asset Advisors |
Add 31.32% |
29,038 |
0.39 |
≡ |
Dodge & Cox |
Add 40.06% |
6,432,600 |
0.70 |
≡ |
Mason Hawkins - Longleaf Partners |
Buy |
279,864 |
1.74 |
≡ |
Bill Miller - Miller Value Partners |
Buy |
507,383 |
1.86 |
≡ |
ValueAct Capital |
Add 19.20% |
2,100,000 |
2.46 |